Product Name

Adefovir Dipivoxil

Name: Adefovir Dipivoxil - LGM Pharma
SKU: 142340-99-6

CAS Number

142340-99-6

LGM Pharma is an API distributor. LGM Pharma supplies APIs as per CGMP with DMF support, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, or pharmacies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:

Adefovir Dipivoxil

CAS Number:

142340-99-6

Indication:

For the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Mode of Action:

Adefovir dipivoxil is a prodrug of adefovir. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA. The inhibition constant (Ki) for adefovir diphosphate for HBV DNA polymerase was 0.1 _M. Adefovir diphosphate is a weak inhibitor of human DNA polymerases _ and _ with Ki values of 1.18 _M and 0.97_M, respectively.

Pharmacodynamics:

Adefovir dipivoxil a diester prodrug of adefovir. Adefovir is an acyclic nucleotide analog with activity against human hepatitis B virus (HBV). The concentration of adefovir that inhibited 50% of viral DNA synthesis (IC50) in vitro ranged from 0.2 to 2.5 _M in HBV transfected human hepatoma cell lines. The combination of adefovir with lamivudine showed additive anti-HBV activity.

Metabolism:

Following oral administration, adefovir dipivoxil is rapidly converted to adefovir. Forty-five percent of the dose is recovered as adefovir in the urine over 24 hours at steady state following 10 mg oral doses. Adefovir is not a substrate of the cytochrome P450 enzymes.

Toxicity:

Renal tubular nephropathy characterized by histological alterations and/or increases in BUN and serum creatinine was the primary dose-limiting toxicity associated with administration of adefovir dipivoxil in animals. Nephrotoxicity was observed in animals at systemic exposures approximately 3Ð10 times higher than those in humans at the recommended therapeutic dose of 10 mg/day.

IUPAC:

[({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2, 2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2, 2-dimethylpropanoate

ATC:

J05AF08

DrugBank:

DB00718 (APRD00781)

Formula:

C₂₀H₂₃N

Molecular Mass:

501.4705

Synonyms:

Adefovir Adefovir pivoxil Adefovirdipivoxl ADV bis-POM PMEA GS-840 PMEA

SMILES:

CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C

AHFS Code:

08:18.3

InChi:

WOZSCQDILHKSGG-UHFFFAOYSA-N

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210.

Ask us about this product

API’s From Quality Manufacturers:

Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
Premium quality GMP certified and fully accredited API manufacturing plants
Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
Regulatory and technical assistance towards any submission type based on specific customer requirements

Adefovir Dipivoxil

142340-99-6

Ask us about this product

API’s From Quality Manufacturers:

Find an API Product